Finance

Lists
Why is 600721 up 9.96%?
Dive Deeper
600721:SHA
Xinjiang Bai Hua Cun Pharma Tech Co Ltd
CNÂ¥9.83
+9.96%
(+0.89) 1D
Oct 30, 3:00:01 PM GMT+8  ·   CNY
All symbols
SymbolPriceChange% Change
Generating top insights for 600721...
Open
CNÂ¥8.94
High
CNÂ¥9.83
Low
CNÂ¥8.45
Mkt. cap
3.78B
Avg. vol.
93.15M
Volume
97.35M
Dividend
0.41%
Quarterly dividend
CNÂ¥0.01
Ex-dividend date
May 8, 2026
P/E ratio
152.05
52-wk high
CNÂ¥16.68
52-wk low
CNÂ¥6.25
EPS
CNÂ¥0.06
Shares outstanding
400.39M
No. of employees
690
Open
CNÂ¥8.94
High
CNÂ¥9.83
Low
CNÂ¥8.45
Mkt. cap
3.78B
Avg. vol.
93.15M
Volume
97.35M
Dividend
0.41%
Quarterly dividend
CNÂ¥0.01
Ex-dividend date
May 8, 2026
P/E ratio
152.05
52-wk high
CNÂ¥16.68
52-wk low
CNÂ¥6.25
EPS
CNÂ¥0.06
Shares outstanding
400.39M
No. of employees
690
News stories
From web sources and news partners
About Xinjiang Bai Hua Cun Pharma Tech Co Ltd
CEO-
Employees690
Founded1959
Headquarters-
SectorPharmaceutical industry
Websitexjbhc.net
Previous reportsAll values in CNY
Loading Previous Earnings...
Revenue
Net income
All values in CNY
Dec 2025
Mar 2026
Jun 2026
Sep 2026
Revenue
89.71M
67.18M
90.17M
73.19M
Cost of goods sold
85.29M
34.92M
55.22M
38.97M
Cost of revenue
85.29M
34.92M
55.22M
38.97M
Research and development expenses
6.30M
4.03M
5.23M
4.83M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
14.60M
15.21M
16.69M
19.17M
Operating expense
16.82M
22.87M
29.84M
15.46M
Total operating expenses
102.11M
57.80M
85.06M
54.44M
Operating income
-12.40M
9.38M
5.11M
18.75M
Other non operating income
-19.62K
-14.06K
-72.30K
-11.14M
EBT including unusual items
5.44M
7.26M
9.45M
2.58M
EBT excluding unusual items
-14.36M
10.38M
5.79M
7.62M
Income tax expense
-2.57M
620.69K
1.34M
517.74K
Effective tax rate
-47.26%
8.55%
14.14%
20.09%
Other operating expenses
1.44M
1.40M
1.14M
471.99K
Net income
8.01M
6.64M
8.12M
2.06M
Net profit margin
8.93%
9.89%
9.00%
2.81%
Earnings per share
-
-
-
-
Interest and investment income
-
1.09M
749.00K
79.79K
Interest expense
-1.88M
-79.79K
-
-69.88K
Net interest expenses
-1.88M
1.01M
749.00K
9.91K
Depreciation and amortization charges
-
-
-
-
EBITDA
-7.94M
13.84M
9.69M
23.20M
Gain or loss from assets sale
-884.00
-
-
-
Upcoming events
AI content may include mistakes. Learn more
Google apps